Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.

Sunlight worsens hair loss; protect scalp.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Hair camouflage offers various options for hair loss, helping reduce psychological impact.

Demodex mites rarely cause scalp infections leading to hair loss, but when they do, treatment is effective.

Corkscrew and cigarette-ash-shaped hairs in tinea capitis are caused by internal hair degradation and external resistance.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Various hair camouflage options help people with hair loss improve appearance.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.